Skip to Main Content

Paper Details

Clinical outcomes among young patients with Fabry disease who initiated agalsidase beta treatment before 30 years of age: An analysis from the Fabry Registry.
Mol Genet Metab
5
2023
Author NameAffiliation
John L JefferiesThe Cardiovascular Institute, University of Tennessee Health Science Center
Amel KaraaMassachusetts General Hospital, Harvard Medical School
  • 1 - 2

Datasets

Release 1.2